Friends of Cancer Research Campaign

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 12
Volume 5
Issue 12

WASHINGTON--The national cancer community has joined together to create a nonprofit organization, the Friends of Cancer Research, to commemorate the 25th anniversary of the National Cancer Act through a public awareness and education campaign on the importance of cancer research.

WASHINGTON--The national cancer community has joined togetherto create a nonprofit organization, the Friends of Cancer Research,to commemorate the 25th anniversary of the National Cancer Actthrough a public awareness and education campaign on the importanceof cancer research.

The Friends board includes members of the groups most active inthe fight against cancer, including the National Cancer AdvisoryBoard, National Coalition for Cancer Survivorship, Presidents'Cancer Panel, ASCO, AACR, National Alliance of Breast Cancer Organizations,Oncology Nursing Society, National Coalition for Cancer Research,American Cancer Society, and a number of prominent US cancer centers.

The campaign will include events and public forums at which RichardKlausner, MD, director of the National Cancer Institute, and othersenior officials will report to the American people on the stateof cancer research. These events will also provide an opportunityfor the cancer community and other interested parties to identifytheir most important research priorities for the coming years.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
For patients with peritoneal carcinomatosis, integrating PIPAC into a treatment regimen does not interrupt their systemic therapy.